Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma <it>in situ</it>
<p>Abstract</p> <p>Background</p> <p>Endocrine therapy is commonly recommended in the adjuvant setting for patients as treatment for ductal carcinoma <it>in situ </it>(DCIS). However, it is unknown whether a neoadjuvant (preoperative) anti-estrogen approach to DCIS results in any biological change....
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2009-08-01
|
| Saila: | BMC Cancer |
| Sarrera elektronikoa: | http://www.biomedcentral.com/1471-2407/9/285 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|